logo
Breaking the chain: strengthening Europe's preparedness for disease outbreaks

Breaking the chain: strengthening Europe's preparedness for disease outbreaks

Euractiv01-07-2025
Preventing future pandemics means preparing for both known and unknown viral disease threats. Since it was added to the WHO R&D Blueprint list of diseases in 2018, 'Disease X' has become the 'bogeyman' for scientists and health professionals across the globe.
Disease X refers to an unexpected and unknown outbreak of a contagious or infectious disease that could cause a pandemic similar in scale to COVID-19. As an elusive pathogen, we don't know if we can prevent the occurrence of Disease X, but we do know that from SARS to MERS, swine flu, Ebola, and avian influenza, animal-borne diseases have been the source of every major pandemic in the past century.
As a zoonotic disease is likely the prime candidate for the next pandemic, work should begin with a better understanding of the risks of emergence of zoonotic infectious diseases. Whilst the recently published WHO Pandemic Agreement calls on governments to take measures to identify and address drivers of infectious disease at the human-animal-environment interface, with the aim of early prevention of pandemics, the EU Preparedness Union Strategy makes no mention of animal health or zoonotic disease threats. The concrete role of the animal health sector in the EU Health Emergency Preparedness and Response Authority (HERA) is also not yet clearly defined.
'One Health' — integrating human, animal and environmental health — is of course mentioned by both the WHO and HERA, but investment in the prevention of animal-borne diseases, or zoonoses, as well as veterinary science and animal health more generally, is all too often overlooked in preparedness planning.
A 2022 World Bank report estimated that investing US$10–11 billion annually in One Health prevention - including US$2.1 billion per year to bring public veterinary services up to international standards, and US$5 billion to improve farm biosecurity - could prevent pandemics that would carry vastly higher costs to manage and control. If we take the COVID-19 pandemic as an example, the International Monetary Fund's World Economic Outlook (IMF 2022) projected the cumulative output loss from the pandemic through 2024 to be about US$13.8 trillion.
COVID-19's enduring devastation serves as a stark reminder of a critical and persistent risk: the systemic neglect of animal health systems.
So, if we are serious about taking the necessary measures to prevent the next pandemic, we must learn from past failures and act both accordingly and decisively. This starts with better prioritising animal health for the benefits it can bring as our frontline of defence protecting against future pandemics.
In today's interconnected world, a health risk in one location, in one species, is a risk for all due to globalised markets and travel, and the ability of pathogens to spread through various means, including direct contact, indirect contact, airborne transmission, and via vectors like insects. To bolster global health security, it is imperative to incorporate binding infrastructure and workforce provisions, including veterinary capacity and flexible regulation for rapid response to disease outbreaks, into preparedness planning.
With over three-quarters of emerging infectious diseases coming from zoonotic pathogens, it is clear that we must enhance existing animal disease surveillance systems so they can identify potential threats to animal and human health in good time. We also need to increase the number of qualified vets and veterinary paraprofessionals and support animal owners' access to veterinary services. And with one in five farm animals lost due to disease each year, access to safe and effective vaccines and medicines for animals, as well ability to use these must be assured.
With Europe facing numerous outbreaks of animal diseases such as bird flu, foot-and-mouth disease, and bluetongue virus, there is a clear need to implement disease prevention programmes, endorse the use of preventive measures such as vaccines and parasite control, and enhance basic animal health care. Although bluetongue and FMD are not zoonotic, bird flu is. Fortunately the risk of human infection remains low, but it has been reported in dairy cattle in the US.
Without wishing to be alarmist, the EU and international governments need to realise that the more animals are affected by a disease, the greater the possibility for the virus to jump from mammal to mammal, and potentially also to people. Enhancing efforts in the field of animal disease prevention would not only reduce the huge socio-economic costs associated with a more reactive approach to disease outbreaks in animals, but they could also drastically reduce the potential One Health risks.
Investing in animal health is non-negotiable. It's one of the most effective, proactive and lucrative investment strategies for enhanced preparedness we can take to stop emerging diseases before they ever endanger people and their livelihoods.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ariane 6 rocket launches with Europe's landmark extreme weather satellite in tow
Ariane 6 rocket launches with Europe's landmark extreme weather satellite in tow

Euractiv

time2 days ago

  • Euractiv

Ariane 6 rocket launches with Europe's landmark extreme weather satellite in tow

AFP Aug 13, 2025 12:00 2 min. read News Service Produced externally by an organization we trust to adhere to journalistic standards. An Ariane 6 rocket blasted off carrying Europe's next generation satellite for warning against extreme weather events from the European spaceport in French Guyana on Wednesday. As many European countries simmer in a deadly heatwave, the European Organisation for the Exploitation of Meteorological Satellites (EUMETSAT) said its MetOp-SGA1 satellite will give "earlier warnings to help protect lives and property from extreme weather". "Metop-SGA1 observations will help meteorologists improve short- and medium-term weather models that can save lives by enabling early warnings of storms, heatwaves, and other disasters, and help farmers to protect crops, grid operators to manage energy supply, and pilots and sailors to navigate safely," the agency added. The rocket carrying the four-tonne satellite took off from Kourou space base in French Guyana. MetOp-SGA1 was to be put into an 800 kilometre high orbit. It will be Europe's first contribution to a US-led programme, the Joint Polar System, putting up satellites orbiting between the north and south poles. The six monitoring instruments on the satellite are twice as precise as the agency's existing satellite, IASI. It will monitor ocean and land temperatures, water vapour and greenhouse gases in the atmosphere, the amount of desert dust and cloud cover. "Extreme weather has cost Europe hundreds of billions euros and tens of thousands of lives over the past 40 years – storms like Boris, Daniel and Hans, record heatwaves and fierce wildfires are just the latest reminders," said Phil Evans, EUMETSAT director-general. "The launch of Metop-SGA1 is a major step forward in giving national weather services in our member states sharper tools to save lives, protect property, and build resilience against the climate crisis." The liftoff was the third overall and second commercial mission by Ariane 6 since its massively delayed inaugural flight in July last year. The Ariane company said that it had 32 launches planned from Kourou in coming years and that it was aiming to carry out nine or 10 launches each year.

€10 million in USAID-funded contraceptives to be incinerated in France
€10 million in USAID-funded contraceptives to be incinerated in France

Euractiv

time23-07-2025

  • Euractiv

€10 million in USAID-funded contraceptives to be incinerated in France

Several sources told Reuters that the Trump administration preferred to pay for the destruction of still-usable contraceptives, worth over €10 million and stored in Belgium, rather than sell them to NGOs. The US-funded supplies have been held in a Belgian warehouse since the suspension of international aid via USAID in January, and are now expected to be destroyed, the sources said. The stock is to be transported to France, where a medical waste facility will handle its incineration. The Trump administration is expected to spend nearly $160,000 to destroy the stockpile of condoms, pills, and other contraceptive methods, which are set to expire between April 2027 and September 2031. To avoid what many consider a senseless waste, several NGOs offered to purchase the supplies from Washington – but to no avail. The NGO MSI Reproductive Choices proposed covering the cost of repackaging the supplies without the USAID logo and shipping them to countries in need, but the offer was rejected. "No viable alternative" The Belgian Ministry of Foreign Affairs confirmed to Reuters that it had held discussions with US authorities and had 'explored all possible options to prevent the destruction, including temporary relocation.' 'Despite these efforts, and with full respect for our partners, no viable alternative could be secured,' the ministry said in a statement sent to the news agency. 'Sexual and reproductive health must not be subject to ideological constraints,' it added. This decision by Washington is part of a broader dismantling of USAID, once the world's largest donor of humanitarian aid, with an annual budget of around $40 billion. A 90-day freeze on USAID operations was declared on 20 January, the day President Trump took office. Two weeks later, Elon Musk, then one of his top advisers, announced the shutdown of the agency's global health programmes. In March, Secretary of State Marco Rubio confirmed that 83% of USAID programmes would be terminated. On 1 July, the agency's remaining operations were folded into the State Department. (bms, aw)

EU must take lead role on pharma, and patient access, says Czech minister
EU must take lead role on pharma, and patient access, says Czech minister

Euractiv

time17-07-2025

  • Euractiv

EU must take lead role on pharma, and patient access, says Czech minister

Czech Deputy Health Minister Michaela Matoušková (STAN, EPP) is calling for stronger EU action on pharmaceutical policy, better coordination on digital health, and a more unified approach to patient access to innovative medicines across the bloc. In an interview with Euractiv, Matoušková urged the EU to move from passive coordination to proactive support, particularly when it comes to ensuring equitable access to innovative medicines and building the Union's strategic autonomy in healthcare. Matoušková, who took office in February this year, believes the COVID-19 pandemic and the EU's fragmented response exposed structural weaknesses that Brussels now has an opportunity to address. 'We have the brains, but we lack coordination – and that is the role of the European Union,' she said. She argues that the EU level is the only viable arena to tackle the uneven and delayed access to new medicines that persists across member states. 'Some smaller states do not introduce medicines, even though the European Medicines Agency (EMA) has approved them, as quickly as others. If we really want a patient-focused approach, this has to change,' she said. The Czech deputy minister voiced strong support for the pharmaceutical package currently negotiated by EU institutions in the trilogues. However, she underlined that success will depend on finding the right balance between patient access, price and industry incentives. 'The compromise is crucial,' she said. She noted that the Commission's proposal rightly aims to increase access to medicines in all member states, but that this will require cooperation from industry. 'They need to understand what we are trying to achieve: speed of rollout and availability,' Matoušková said. Innovation vouchers One of her concerns is the growing trend of pharmaceutical companies threatening to pull out of Europe in response to proposed changes in market exclusivity rules. 'The USA invests significantly more – three times more than the EU, I believe. But it's not just about money. It's about how fast we bring medicines to market and how long the data and market protection lasts,' she said. Matoušková acknowledged the financial pressures innovators face and expressed support for maintaining incentives that allow for returns on investment. To bridge the interests of both patients and industry, she supported 'a system of innovation vouchers' as a complementary tool to support faster development and approval of new drugs, while maintaining investment appeal. She also addressed the broader relationship between innovation and generics, noting, 'I think generics will always be here. But we need to push for innovation, that is what we need to protect.' Matoušková also sees digital health as an area where EU leadership is urgently needed. While the European Health Data Space regulation has opened a promising debate, the deputy minister warns that implementation is lagging in some areas. 'We would like to have shared medical documentation, but we are missing regional data networks. We do not have enough infrastructure to make it work,' said Matoušková. She believes the EU should step in with funding and coordination. 'The EU should provide the legal framework, the conditions, and the funding. The EU should be the roof over the whole structure,' she said. Cross-border cooperation Her ambition is also to see greater EU involvement in cross-border emergency services. 'Why do we need bilateral treaties for cross-border emergency care? We could define it at the EU level,' she said. In the longer term, Matoušková urges Brussels to invest in services that reflect demographic changes and make a difference on the ground, such as palliative care and home-based support for older people. 'Personally, I am not a fan of building more facilities. Care should move closer to patients, into the field, into their homes,' she said. She would also welcome more EU guidance on workforce reform, including a broader debate on prescription rights for qualified non-physician personnel, adding that, 'We have very erudite non-physician professionals in Czechia, but they haven't been granted the appropriate competences.' Her message to EU policymakers is clear: health policy must be treated as a strategic investment. 'We should see the EU not as a repressive body, but as a source of change – an institution that supports innovation. Not as a dictator, but as a partner that helps address our needs,' she said. [Edited by Vasiliki Angouridi, Brian Maguire]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store